AnodyneWiki

Disulfiram

Disulfiram
Disulfiram
Molecular structure drawn from PubChem coordinates
Physical properties
[]
Molecular mass296.50 g/mol [1]
AppearanceWHITE TO OFF-WHITE CRYSTALLINE POWDER [1]
OdorSlight odor. [1]
TasteSLIGHTLY BITTER TASTE [1]
Density1.27 at 68 °F (NTP, 1992) - Denser than water; will sink [1]
Melting point158 °F (NTP, 1992) [1]
Boiling point243 °F at 17 mmHg (NTP, 1992) [1]
Solubilityless than 0.1 mg/mL at 70 °F (NTP, 1992) [1]
Predicted LogP3.9 [1]
Structural Identifiers
[]
Molecular formulaC10H20N2S4
IUPAC namediethylcarbamothioylsulfanyl N,N-diethylcarbamodithioate
SMILESCCN(CC)C(=S)SSC(=S)N(CC)CC
InChIInChI=1S/C10H20N2S4/c1-5-11(6-2)9(13)15-16-10(14)12(7-3)8-4/h5-8H2,1-4H3
InChIKeyAUZONCFQVSMFAP-UHFFFAOYSA-N
CAS number97-77-8
UNIITR3MLJ1UAI
PubChem CID3117
Pharmacokinetics[]
Elimination half-life7.3 +/-1.5 hours[3][4]
MetabolismIn Liver to diethylthiocarbamate
Routes of administrationBy mouth, subdermal implant
Toxicity
[]
Mouse:
- intraperitoneal: 75 mg/kg
- oral: 1980 mg/kg
Rabbit:
- oral: 2050 mg/kg
Rat:
- oral: 500 mg/kg
- oral: 8.6g/kg
 [1]

Disulfiram (also known as Tetraethylthiuram disulfide, Antabuse, Bis(diethylthiocarbamoyl) disulfide, Esperal, Teturam, Alcophobin, Antabus, Anticol, Exhorran or Abstinyl).

Chemistry

 []

Disulfiram is achiral.

Disulfiram matches Lipinski's rule of five.

Pharmacology

Mechanism of action []

Disulfiram blocks the oxidation of alcohol at the acetaldehyde stage during alcohol metabolism following disulfiram intake causing an accumulation of acetaldehyde in the blood producing highly unpleasant symptoms. Disulfiram blocks the oxidation of alcohol through its irreversible inactivation of aldehyde dehydrogenase, which acts in the second step of ethanol utilization. In addition, disulfiram competitively binds and inhibits the peripheral benzodiazepine receptor, which may indicate some value in the treatment of the symptoms of alcohol withdrawal, however this activity has not been extensively studied. [1]

Interactions []

Interaction mechanisms documented in (number of interacting drugs):

inhibition24

Medical side effects []

32 side effects listed on drug labels in (disulfiram).

  • Asthenia
  • Fatigue
  • Dermatitis atopic
  • Dizziness
  • Somnolence
  • Lassitude
  • Fatigability
  • Breath odour
  • Headache
  • Hepatitis
  • Jaundice
  • Neuritis
  • Neuropathy peripheral
  • Neuropathy
  • Hypoaesthesia
  • Sensory loss
  • Optic neuritis
  • Pain
  • Polyneuropathy
  • Psychotic disorder
  • Stress
  • Hepatic failure
  • Hepatic necrosis
  • Eye pain
  • Dermatitis acneiform
  • Tenderness
  • Abdominal discomfort
  • Erectile dysfunction
  • Rash
  • Hepatitis fulminant
  • Peripheral sensorimotor neuropathy
  • Paraesthesia

Indications

  • Alcoholism
  • Flushing
  • Lipids increased
  • Nausea
  • Palpitations
  • Throbbing headache
  • Vomiting

Experience reports

Erowid

There are currently 1 experience reports involving disulfiram on : []

 []

  • Australia: Disulfiram is a S6 / S4.
  • Brazil: Disulfiram is a C1.[5]
  • United Kingdom: Disulfiram is Prescription only.
  • United States: Disulfiram is Prescription only.

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 3117, Disulfiram. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/3117
  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Disulfiram. UNII: TR3MLJ1UAI. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/TR3MLJ1UAI
  3. Disulfiram. PubChem. https://pubchem.ncbi.nlm.nih.gov/compound/Disulfiram
  4. Lanz J, Biniaz-Harris N, Kuvaldina M, Jain S, Lewis K, Fallon BA. Disulfiram: Mechanisms, Applications, and Challenges. Antibiotics. March 2023; 12(3):1234. PMID 36978391. https://doi.org/10.3390/antibiotics12030524
  5. RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-03-31. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992

Data sources []

SourceStatusUpdated (UTC)
dosingmissing (no dosing statistics)2026-11-20 20:01:53
drugspromissing (no DrugsPRO reagent data)2026-11-20 20:01:49
erowidok2026-11-20 20:01:51
gsrsok2026-11-20 20:01:49
hmdbmissing (hmdb.ca refused automated access to HMDB0014960)2026-11-20 20:01:49
keggok2026-11-20 20:01:51
pubchemok2026-11-20 20:01:48
redditmissing (no r/tripreports posts mention it)2026-11-20 20:01:49
siderok2026-11-20 20:01:49
structureok2026-11-20 20:01:49
wikipediaok2026-11-20 20:01:49